TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 82 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $295,000 | -7.2% | 4,642 | +5.0% | 0.00% | – |
| Q2 2021 | $318,000 | -0.3% | 4,419 | +2.2% | 0.00% | – |
| Q1 2021 | $319,000 | +14.7% | 4,322 | +14.1% | 0.00% | – |
| Q4 2020 | $278,000 | +18.3% | 3,788 | -11.4% | 0.00% | – |
| Q3 2020 | $235,000 | -19.2% | 4,276 | -2.2% | 0.00% | -100.0% |
| Q2 2020 | $291,000 | -7.6% | 4,372 | -15.1% | 0.00% | 0.0% |
| Q1 2020 | $315,000 | -33.0% | 5,151 | -3.6% | 0.00% | 0.0% |
| Q4 2019 | $470,000 | +13.8% | 5,341 | -2.5% | 0.00% | 0.0% |
| Q3 2019 | $413,000 | -18.4% | 5,480 | -7.4% | 0.00% | 0.0% |
| Q2 2019 | $506,000 | +48.8% | 5,921 | +153.9% | 0.00% | 0.0% |
| Q1 2016 | $340,000 | +19.7% | 2,332 | +25.6% | 0.00% | 0.0% |
| Q4 2015 | $284,000 | – | 1,856 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 565,951 | $24,483,000 | 8.44% |
| Murchinson Ltd. | 162,703 | $7,039,000 | 1.34% |
| Eversept Partners, LP | 220,286 | $9,529,572 | 0.73% |
| BRANDES INVESTMENT PARTNERS, LP | 379,322 | $16,410,000 | 0.35% |
| Analyst IMS Investment Management Services Ltd. | 17,657 | $764,000 | 0.07% |
| Claret Asset Management Corp | 7,279 | $315,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 326,427 | $14,086,000 | 0.06% |
| Renaissance Technologies | 678,300 | $29,343,000 | 0.03% |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 191,820 | $8,298,000 | 0.03% |
| ARK Investment Management | 55,566 | $2,404,000 | 0.01% |